Chris Peltola
About Chris Peltola
Chris Peltola serves as the Assistant Vice President of Mergers & Acquisitions at Kaufman Hall, where he specializes in healthcare transactions and valuation analyses. He has a background in economics from the University of Michigan and has held various roles in the M&A sector since 2015.
Current Role at Kaufman Hall
Chris Peltola serves as the Assistant Vice President of Mergers & Acquisitions at Kaufman Hall. He has held this position since 2021, focusing on leading healthcare transactions and engagements for clients. His responsibilities include conducting valuation analyses and evaluating strategic and growth options for various organizations. Peltola's expertise in the M&A field is complemented by his involvement in both sell-side and buy-side transactions.
Previous Experience at Kaufman Hall
Prior to his current role, Chris Peltola worked at Kaufman Hall in various capacities. He served as an Associate in Mergers & Acquisitions from 2017 to 2019 and then as a Senior Associate from 2019 to 2021. During his tenure, he contributed to the firm's M&A practice, focusing on healthcare-related transactions and providing analytical support for client engagements.
Experience at Northern Trust Corporation
Chris Peltola's career includes experience at Northern Trust Corporation, where he worked as a Consultant in Hedge Fund Services for five months in 2016. He later served as a Senior Analyst in the same department from 2015 to 2016. His role involved providing analytical support and consulting services within the hedge fund sector.
Education and Qualifications
Chris Peltola earned a Bachelor of Science degree in Economics from the University of Michigan, where he studied from 2011 to 2015. He also pursued further education at the CFA Institute, enhancing his knowledge and skills in finance and investment analysis. His educational background supports his expertise in mergers and acquisitions.
Mergers and Acquisitions Expertise
Chris Peltola has developed significant expertise in the mergers and acquisitions sector. He is involved in evaluating joint ventures and assessing strategic growth options for clients. His experience encompasses a range of M&A activities, including conducting valuation analyses and managing complex transactions in the healthcare industry.